Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
To conduct prospective studies to confirm the value of circulating tumor DNA and its abnormal methylation in longitudinal monitoring of patients undergoing kidney cancer surgery.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Newly diagnosed renal cell carcinoma
• Without any treatment
• Agree and accept radical surgical treatment
• Signed written informed consent
• ECOG(Eastern Cooperative Oncology Group) performance is 0 or 1
• Follow up protocol and related procedures
Locations
Other Locations
China
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
RECRUITING
Nanjing
Contact Information
Primary
Le Qe, M.D.
septsoul@hotmail.com
15720625951
Time Frame
Start Date: 2022-12-26
Estimated Completion Date: 2030-06
Participants
Target number of participants: 450
Related Therapeutic Areas
Sponsors
Leads: Jinling Hospital, China